Page 44 - Cautionary Note News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nouveau Monde Announces the Successful Closing of the Previously Announced C$5.75 Million Private Placement Offering The private placement forms part of the previously announced financing, which included a bought deal public offering of C$17 million which was completed in January The net proceeds raised by the Company following these two financings is close to C$22 million Investissement Québec, acting as mandatary for the government of Québec, and Pallinghurst show strong ongoing support, subscribing for the full amount of the … The private placement forms part of the previously announce...

Further advancement of its business plan, strong market conditions and continued confidence and support from The Pallinghurst Group, its largest investor, have enabled Nouveau Monde Graphite Inc. to secure $16.5M from the exercise of previously-issued warrants. As of today, management is of the view that the Company is sufficiently funded for this year’s further development of its mining and value-added projects … Further advancement of its business plan, strong market conditions and continued confidence and support from The Pallinghurst Group, its largest investor, have enabled Nouveau M...

Added 8.3 MMBOE of 1P Reserves Realized 1P Finding and Development Costs of $2.65/boe 1P and 2P Net Asset Value per Share Before Tax of $1.15 and $3.25 1P Reserves Equal 59% of 2P Reserves, Demonstrating Strength of Company’s Proved Reserves Base Achieved Company’s Best Safety Year in 2020: Zero Lost Time Incident Frequency CALGARY, Alberta, Jan. 26, 2021 (GLOBE NEWSWIRE) — Gran Tierra Energy Inc. (“ Gran Tierra” or the “ Company“) (NYSE American:GTE) (TSX:GTE) (LSE: GTE), a company focused on oil exploration and production in Colombia and Ecuador, today announced the Company�...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. MATEON ANNOUNCES POSITIVE INTERIM RESULTS FROM ARTI-19 CLINICAL TRIAL EVALUATING COVID-19 ... Mateon Therapeutics, Inc.January 13, 2021 GMT AGOURA HILLS, California, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB: MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and COVID-19, reported positive interim results from its ARTI-19 clinical trial evaluating ARTIVedaTM against COVID-19. “These interim results suggest that ARTIVeda is a well-tolerated and...

MATEON ANNOUNCES POSITIVE INTERIM RESULTS FROM ARTI-19 CLINICAL TRIAL EVALUATING COVID-19 THERAPEUTIC Mateon Therapeutics, Inc. ARTI-19 CLINICAL TRIAL EVALUATING COVID-19 THERAPEUTIC AGOURA HILLS, California, Jan. 13, 2021 (GLOBE NEWSWIRE) — Mateon Therapeutics, Inc. (OTCQB: MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and COVID-19, reported positive interim results from its ARTI-19 clinical trial evaluating ARTIVeda TM against COVID-19. “These interim results suggest that ARTIVeda is a well-tolerated and effective treatment for COVID-19 that produces a f...